Labial Biopsy in Patients With Tuberculosis Disease - Trial NCT02115854
Access comprehensive clinical trial information for NCT02115854 through Pure Global AI's free database. This phase not specified trial is sponsored by Hopital Lariboisière and is currently Completed. The study focuses on Tuberculosis,Sarcoidosis. Target enrollment is 65 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Hopital Lariboisière
Timeline & Enrollment
N/A
Dec 01, 2010
N/A
Primary Outcome
presence of granuloma on labial biopsy
Summary
The distinction between Tuberculosis disease (TB), a worldwide infective granulomatosis
 requiring long-term antibiotic treatment, and sarcoïdosis, a rare granulomatous disease
 successfully treated with high dose steroids is not straightforward and may delay the
 treatment choice by the physician.
 
 The goal was to evaluate prospectively and consecutively the presence of epithelioid
 granulomas in salivary glands biopsy of patients with TB.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT02115854
Non-Device Trial